Attention!

This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical or pharmaceutical specialist?

Report an adverse reaction
Ru Eng
Main page —
Production

Production

GENERIUM's dedicated manufacturing lines enable the production of genetically engineered medications from cell culture to finished dosage form.

The priority of GENERIUM is the quality of medications, which is ensured through strict compliance with national and international GMP quality standards.

The production capacity of the enterprise allows us to produce a unique range of medications and products.

Our production

Generium-Next finished dosage forms manufacturing plant<br>Zelenograd

Generium-Next finished dosage forms manufacturing plant
Zelenograd

  • Industrial facilities

    >20 000 m2

    with a 3x
    expansion capability

  • Production launch

    2025 Year

Active pharmaceutical ingredient manufacturing plant<br>Volginsky settlement, Vladimir Oblast

Active pharmaceutical ingredient manufacturing plant
Volginsky settlement, Vladimir Oblast

  • Industrial facilities

    > 20 000 m2

  • Production launch

    2021 Year

Finished dosage forms manufacturing plant<br>Volginsky settlement, Vladimir Oblast

Finished dosage forms manufacturing plant
Volginsky settlement, Vladimir Oblast

  • Industrial facilities

    >21 000 m2

    with a 3x
    expansion capability

  • Production launch

    2009 Year

Read more:
Our website uses cookies. You can disable cookie storage in your browser settings. Read more.